IMPE2023 Poster Presentations Pituitary, Neuroendocrinology and Puberty (21 abstracts)
1Centro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE) CONICET – FEI – División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina. 2Hospital de Niños Sor María Ludovica, La Plata, Argentina. 3Hospital Provincial Neuquen Dr. Castro Rendon, Neuquén, Argentina. 4Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Introduction: CPP is the onset of secondary sexual characteristics before the age of 8 years for girls, due to early activation of the hypothalamic-pituitary-gonadal axis. Near 90% of girls have idiopathic CPP, in rare cases, CPP may occur due to intracranial pathology causing organic CPP. Brain Magnetic Resonance Imaging (B-MRI) with gadolinium is the tool to exclude organic CPP. There is controversy regarding the need for MRI testing in CPP girls whose puberty started at age 6 years or older.
Aims: To determine the frequency and characteristics of lesions detected in girls between 6-8 years old with a diagnosis of presumed Idiopathic CPP by B-MRI with and without gadolinium. To evaluate whether the performance of B-MRI should be maintained as a recommendation in girls in the 6-8 years group developing CPP who are considered presumed idiopathic.
Patients and methods: We performed a retrospective observational cohort study. Data from medical records of patients with a history of presumed idiopathic CPP diagnosed between March 2015 and March 2020 from 4 Argentinian hospitals were included. In all patients, B-MRI was performed with 1.5 T scanners using standard T1 - T2 weighted images, with gadolinium contrast. Inclusion criteria: progressive breast development that begins between 6-8 years, growth velocity > Pc 75, bone age advancement greater than 1 year to chronological age, baseline gonadotrophins: LH ≥ 0. 3 mIU/ml or LH stimulated peak ≥ 6 mIU/ml, physical examination and background for consideration in the classification of idiopathic CPP. Exclusion criteria: history of CNS disease, epilepsy, tumors, infiltrative processes, hydrocephalus, myelomeningocele, severe CNS trauma, and genetic or polymalformative syndromes, other causes of peripheral precocious puberty that progress to CPP secondary.
Results: We evaluated 123 clinical records from 4 Argentinian Hospitals. The mean age at the start of CPP was 7.3 ± 0.6 yrs, and the mean age at diagnosis was 8.2 ± 0.7 yrs. Most girls were in Tanner breast stage 3 and biochemical profiles confirmed CPP. Twelve of 123 CPP girls had abnormal MRI (4 Rathke’s cleft cysts, 2 microadenomas, 2 arachnoidal cysts, 3 intraparenchymal lesions, 1 Pineal cyst). No neoplastic lesions nor other lesions that required intervention were identified over follow-up.
Conclusions: In this cohort of 6–8-year-old girls with presumed Idiopathic CPP we found 10% of anomalies in B-MRI, half of them causally related or questionably related to CPP etiology. The need for brain imaging studies must be reconsidered in this age range.